3M India Amends Healthcare Business Agreements

3M India Limited has executed a second amendment agreement (2nd Amendment Agreement) to its previously executed Transaction Agreements related to its healthcare business. These amendments, approved by the board on October 26, 2026, primarily involve removing certain products from the Distribution Agreement, subject to conditions related to Solventum's divestiture of these products to Thermo Fisher. Additionally, the term of the Distribution Agreement for the remaining products has been extended by two years, making its total duration seven years from the execution date. The company also noted name changes for two entities involved: 3M Healthcare US Opco, LLC to Solventum US LLC and 3M Healthcare Intellectual Properties Company to Solventum Intellectual Properties Company.